找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Combination Therapy in Urological Malignancy; Philip H. Smith (Consultant Urologist) Book 1989 Springer-Verlag Berlin Heidelberg 1989 Stag

[复制链接]
查看: 49827|回复: 57
发表于 2025-3-21 16:05:53 | 显示全部楼层 |阅读模式
书目名称Combination Therapy in Urological Malignancy
编辑Philip H. Smith (Consultant Urologist)
视频video
丛书名称Clinical Practice in Urology
图书封面Titlebook: Combination Therapy in Urological Malignancy;  Philip H. Smith (Consultant Urologist) Book 1989 Springer-Verlag Berlin Heidelberg 1989 Stag
描述Any discussion of the present success in management of urological cancers evokes a mixed response. Oncologists and urologists can enjoy the success with chemotherapy for testicular cancers but cannot forget the dismal results with any form of treatment, other than surgery, for renal carcinoma. But these are the less frequent urolegi­ cal tumours: what are the attitudes to the more common prostate and bladder cancers. Intensive study, many clinical trials and much debate lead us to the conclusion that we understand them better, we can tailor the treatment more appropriately to the individual patient but there remains some uncertainty as to the overall success that we have achieved. There have been no striking changes in the 5-year survival data. Clinicians tend to see their success in terms of their special interest. Radiotherapists point to their success in stage-reduction but what are we to do with the many patients whose tumour is unaltered by radiotherapy. Urological surgeons, and especially those who are still influenced by the shadow of Halsted, point to their success in excising the cancer but apart from that highly selected group, what are we to do for the very large number
出版日期Book 1989
关键词Staging; Tumor; cancer; carcinoma; chemotherapy; clinical trial; immunotherapy; kidney; metastatic disease; o
版次1
doihttps://doi.org/10.1007/978-1-4471-1655-4
isbn_softcover978-1-4471-1657-8
isbn_ebook978-1-4471-1655-4Series ISSN 0177-8994
issn_series 0177-8994
copyrightSpringer-Verlag Berlin Heidelberg 1989
The information of publication is updating

书目名称Combination Therapy in Urological Malignancy影响因子(影响力)




书目名称Combination Therapy in Urological Malignancy影响因子(影响力)学科排名




书目名称Combination Therapy in Urological Malignancy网络公开度




书目名称Combination Therapy in Urological Malignancy网络公开度学科排名




书目名称Combination Therapy in Urological Malignancy被引频次




书目名称Combination Therapy in Urological Malignancy被引频次学科排名




书目名称Combination Therapy in Urological Malignancy年度引用




书目名称Combination Therapy in Urological Malignancy年度引用学科排名




书目名称Combination Therapy in Urological Malignancy读者反馈




书目名称Combination Therapy in Urological Malignancy读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

1票 100.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 21:11:07 | 显示全部楼层
发表于 2025-3-22 04:28:28 | 显示全部楼层
发表于 2025-3-22 07:38:21 | 显示全部楼层
Management of Invasive Bladder Neoplasms, any tumour that extends beyond the in situ category, urologically it implies muscle infiltration and uniform recommendations concerning management are lacking. Once infiltration is documented, the ability to control the disease by transurethral resection diminishes, thus, radical surgery, with or w
发表于 2025-3-22 10:22:56 | 显示全部楼层
,Carcinoma of the Prostate — Non-metastatic Disease,In 1988, approximately 99 000 new cases of prostate cancer will be diagnosed in the United States and approximately 28 000 men will die from it (Silverberg and Lubern 1988). It is a disease of ageing men and with the increasing age of the male population worldwide, prostate cancer is expected to bec
发表于 2025-3-22 15:13:32 | 显示全部楼层
发表于 2025-3-22 19:21:40 | 显示全部楼层
Cancer of the Penis, disease which has . been exclusively managed by urological surgeons and oncologists. In its early stages it may be seen and treated by such diverse clinicians as venereologists, dermatologists, general surgeons, radiotherapists and general practitioners. Few doctors, indeed few Oncology Centres, ha
发表于 2025-3-22 21:31:39 | 显示全部楼层
Clinical Trials in Genitourinary Oncology: What Have They Achieved?, experience of the clinician recommending treatment, his time and place of training, and his awareness of the results of clinical trials which have addressed aspects of management relevant to this particular patient. A recent survey of practice relating to urological cancer has demonstrated very div
发表于 2025-3-23 03:04:03 | 显示全部楼层
发表于 2025-3-23 09:03:45 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-28 07:52
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表